Longitudinal Registry Including Patients Treated With Heavy Particles
Recruiting
Observational Study
Cancer
Oncology
Radiation Exposure
Radiotherapy Side Effect
Radiation Toxicity
Rare Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- CNAO National Center of Oncological Hadrontherapy · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia.
By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity.…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients treated with heavy particles at Fondazione CNAO, Pavia
* Patients who have the ability to understand and be willing to sign a written informed consent document
Exclusion Criteria:
* Patients or legal guardians who are unable to understand informed consent document
Contacts